Mid-cap stocks provide a balanced investment option, combining small-cap growth potential with large-cap stability, ideal for long-term wealth building. Similarly, the pharma industry is promising due to increasing demand driven by factors such as rising chronic illnesses, advancements in medical technology, and improved healthcare accessibility.
Investors seeking growth might consider investing in robust mid-cap pharma stocks: Amphastar Pharmaceuticals, Inc. (AMPH), Catalyst Pharmaceuticals, Inc. (CPRX), and ACADIA Pharmaceuticals Inc. (ACAD). Analysts foresee potential increases of 50% or more for these stocks.
